PMID- 35653364 OWN - NLM STAT- MEDLINE DCOM- 20220606 LR - 20220716 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 17 IP - 6 DP - 2022 TI - Super high-resolution single-molecule sequence-based typing of HLA class I alleles in HIV-1 infected individuals in Ghana. PG - e0269390 LID - 10.1371/journal.pone.0269390 [doi] LID - e0269390 AB - Polymorphisms in human leukocyte antigen (HLA) class I loci are known to have a great impact on disease progression in HIV-1 infection. Prevailing HIV-1 subtypes and HLA genotype distribution are different all over the world, and the HIV-1 and host HLA interaction could be specific to individual areas. Data on the HIV-1 and HLA interaction have been accumulated in HIV-1 subtype B- and C-predominant populations but not fully obtained in West Africa where HIV-1 subtype CRF02_AG is predominant. In the present study, to obtain accurate HLA typing data for analysis of HLA association with disease progression in HIV-1 infection in West African populations, HLA class I (HLA-A, -B, and -C) four-digit allele typing was performed in treatment-naive HIV-1 infected individuals in Ghana (n = 324) by a super high-resolution single-molecule sequence-based typing (SS-SBT) using next-generation sequencing. Comparison of the SS-SBT-based data with those obtained by a conventional sequencing-based typing (SBT) revealed incorrect assignment of several alleles by SBT. Indeed, HLA-A*23:17, HLA-B*07:06, HLA-C*07:18, and HLA-C*18:02 whose allele frequencies were 2.5%, 0.9%, 4.3%, and 3.7%, respectively, were not determined by SBT. Several HLA alleles were associated with clinical markers, viral load and CD4+ T-cell count. Of note, the impact of HLA-B*57:03 and HLA-B*58:01, known as protective alleles against HIV-1 subtype B and C infection, on clinical markers was not observed in our cohort. This study for the first time presents SS-SBT-based four-digit typing data on HLA-A, -B, and -C alleles in Ghana, describing impact of HLA on viral load and CD4 count in HIV-1 infection. Accumulation of these data would facilitate high-resolution HLA genotyping, contributing to our understanding of the HIV-1 and host HLA interaction in Ghana, West Africa. FAU - Nii-Trebi, Nicholas I AU - Nii-Trebi NI AD - AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan. AD - Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. AD - Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, University of Ghana, Accra, Ghana. FAU - Matsuoka, Saori AU - Matsuoka S AD - AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan. FAU - Kawana-Tachikawa, Ai AU - Kawana-Tachikawa A AD - AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan. AD - Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. AD - Institute of Medical Science, University of Tokyo, Tokyo, Japan. FAU - Bonney, Evelyn Y AU - Bonney EY AUID- ORCID: 0000-0002-6634-8742 AD - Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana. FAU - Abana, Christopher Z AU - Abana CZ AD - Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana. FAU - Ofori, Sampson B AU - Ofori SB AD - Department of Medicine, Koforidua Government Hospital, Eastern Region, Ghana. FAU - Mizutani, Taketoshi AU - Mizutani T AD - Institute of Medical Science, University of Tokyo, Tokyo, Japan. FAU - Ishizaka, Aya AU - Ishizaka A AD - Institute of Medical Science, University of Tokyo, Tokyo, Japan. FAU - Shiino, Teiichiro AU - Shiino T AD - AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan. FAU - Ohashi, Jun AU - Ohashi J AD - Department of Biological Sciences, Graduate School of Sciences, University of Tokyo, Tokyo, Japan. FAU - Naruse, Taeko K AU - Naruse TK AD - Department of Protozoology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan. AD - Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan. FAU - Kimura, Akinori AU - Kimura A AD - Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan. AD - Institute of Research, Tokyo Medical and Dental University, Tokyo, Japan. FAU - Kiyono, Hiroshi AU - Kiyono H AD - Institute of Medical Science, University of Tokyo, Tokyo, Japan. AD - Future Medicine Education and Research Organization, Chiba University, Chiba, Japan. AD - CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines, Department of Medicine, University of California San Diego, San Diego, California, United States of America. FAU - Ishikawa, Koichi AU - Ishikawa K AD - AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan. FAU - Ampofo, William K AU - Ampofo WK AD - Department of Virology, Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana. FAU - Matano, Tetsuro AU - Matano T AUID- ORCID: 0000-0003-3096-6749 AD - AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan. AD - Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, Japan. AD - Institute of Medical Science, University of Tokyo, Tokyo, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20220602 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (HLA-A Antigens) RN - 0 (HLA-B Antigens) RN - 0 (HLA-C Antigens) RN - 0 (Histocompatibility Antigens Class I) SB - IM MH - Alleles MH - Disease Progression MH - Ghana MH - *HIV Infections MH - *HIV Seropositivity/genetics MH - *HIV-1/genetics MH - HLA-A Antigens/genetics MH - HLA-B Antigens/genetics MH - HLA-C Antigens/genetics MH - Histocompatibility Antigens Class I/genetics MH - Humans PMC - PMC9162337 COIS- The authors have declared that no competing interests exist. EDAT- 2022/06/03 06:00 MHDA- 2022/06/07 06:00 PMCR- 2022/06/02 CRDT- 2022/06/02 13:34 PHST- 2021/09/05 00:00 [received] PHST- 2022/05/19 00:00 [accepted] PHST- 2022/06/02 13:34 [entrez] PHST- 2022/06/03 06:00 [pubmed] PHST- 2022/06/07 06:00 [medline] PHST- 2022/06/02 00:00 [pmc-release] AID - PONE-D-21-28770 [pii] AID - 10.1371/journal.pone.0269390 [doi] PST - epublish SO - PLoS One. 2022 Jun 2;17(6):e0269390. doi: 10.1371/journal.pone.0269390. eCollection 2022.